Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$17.05 +0.16 (+0.95%)
As of 08/22/2025 04:00 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$16.69
$18.33
50-Day Range
$12.53
$19.45
52-Week Range
$8.89
$24.50
Volume
892,018 shs
Average Volume
784,221 shs
Market Capitalization
$741.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.56
Consensus Rating
Moderate Buy

Company Overview

Beta Bionics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

BBNX MarketRank™: 

Beta Bionics scored higher than 53% of companies evaluated by MarketBeat, and ranked 528th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Beta Bionics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 7 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Beta Bionics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Beta Bionics' stock forecast and price target.
  • Price to Book Value per Share Ratio

    Beta Bionics has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for BBNX.
  • Dividend Yield

    Beta Bionics does not currently pay a dividend.

  • Dividend Growth

    Beta Bionics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for BBNX.
  • News Sentiment

    Beta Bionics has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Beta Bionics this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    3 people have added Beta Bionics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Beta Bionics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $444,376.00 in company stock.

  • Read more about Beta Bionics' insider trading history.
Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX stock has decreased by 28.4% and is now trading at $17.05.

Beta Bionics, Inc. (NASDAQ:BBNX) announced its quarterly earnings results on Tuesday, July, 29th. The company reported ($0.39) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.51) by $0.12. The company earned $23.24 million during the quarter, compared to the consensus estimate of $19.73 million.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an initial public offering (IPO) on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share.

Beta Bionics's lock-up period expired on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Since the end of Beta Bionics' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Top institutional investors of Beta Bionics include Eventide Asset Management LLC (11.35%), Soleus Capital Management L.P. (8.79%), Sands Capital Alternatives LLC (8.21%) and Divisadero Street Capital Management LP (2.18%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/29/2025
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
CIK
1674632
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$16.00
Potential Upside/Downside
+32.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.68
Quick Ratio
13.79

Sales & Book Value

Annual Sales
$65.12 million
Price / Sales
11.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.94 per share
Price / Book
2.46

Miscellaneous

Outstanding Shares
43,470,000
Free Float
N/A
Market Cap
$741.16 million
Optionable
N/A
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners